Children often respond differently to treatments than adults due to their developing bodies and unique genetic profiles. Targeted therapy offers the potential for more effective and less toxic treatments for pediatric patients by focusing on the specific genetic and molecular abnormalities found in their diseases. This approach is particularly valuable in pediatric oncology, where traditional therapies can have long-lasting side effects that impact growth and development.
